SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bal Pharma informs about acquisition

23 Mar 2018 Evaluate

Bal Pharma has informed that the Company has acquired 100% shareholding, management control and ownership of Golden Drugs an Udaipur, Rajasthan based private limited Company, which is in the business of manufacturing of APIs/ Bulk Drugs. The Board of Directors of the Company at their meeting held on 22.3.2018 has approved the signing of the share purchase agreement (SPA) with the Directors and shareholders of Golden Drugs, with a purchase consideration of Rs 20.66 per equity shares of Rs 10 each of the said Company.

The above information is a part of company’s filings submitted to BSE.

Bal Pharma Share Price

78.45 1.75 (2.28%)
23-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1679.85
Dr. Reddys Lab 1333.05
Cipla 1305.85
Zydus Lifesciences 947.10
Lupin 2340.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×